# An Exploratory Basket Study of Pyrotinib Maleate Tablets in HER2 Mutated or Amplified of Metastatic Solid Tumors

> **NCT05274191** · PHASE2 · UNKNOWN · sponsor: **Zhongshan Hospital Xiamen University** · enrollment: 60 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** Pyrotinib Maleate
- **OTHER:** standard regimen

## Key facts

- **NCT ID:** NCT05274191
- **Lead sponsor:** Zhongshan Hospital Xiamen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-04
- **Primary completion:** 2022-03-15
- **Final completion:** 2024-03-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05274191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05274191, "An Exploratory Basket Study of Pyrotinib Maleate Tablets in HER2 Mutated or Amplified of Metastatic Solid Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05274191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*